The Finnegan Scoring System, also known as the Neonatal Abstinence Scoring System (NASS), is a widely used tool to assess and quantify the severity of withdrawal symptoms in newborns exposed to opioids or other substances in utero. Developed by Dr. Loretta Finnegan in the 1970s, this scoring system helps healthcare providers determine the need for pharmacologic and non-pharmacologic interventions.